SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon - Quaterly Results

30 Jan 2025 Evaluate
A minor change in the total revenue was seen in the December 2024 quarter. The total revenue for the quarter stood at Rs. 5628.00 millions against Rs. 5628.00 millions during year ago period.The company almost doubled its revenue to Rs. 5840.00 millions  from Rs. 240.00 millions in the quarter ended December 2024.Operating Profit reported a sharp decline to 955.00 millions from 1198.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 5628.00 5628.00 0.00 15988.00 15947.00 0.26 21273.00 19929.00 6.74
Other Income 642.00 485.00 32.37 1796.00 1541.00 16.55 1930.00 2714.00 -28.89
PBIDT 955.00 1198.00 -20.28 2934.00 3646.00 -19.53 4557.00 2949.00 54.53
Interest 653.00 560.00 16.61 1802.00 1593.00 13.12 1988.00 696.00 185.63
PBDT 6377.00 638.00 899.53 7207.00 2198.00 227.89 2714.00 30881.00 -91.21
Depreciation 338.00 309.00 9.39 948.00 913.00 3.83 1211.00 1169.00 3.59
PBT 6039.00 329.00 1735.56 6259.00 1285.00 387.08 1503.00 29712.00 -94.94
TAX 199.00 89.00 123.60 378.00 232.00 62.93 310.00 1228.00 -74.76
Deferred Tax 115.00 -34.00 -438.24 138.00 -12.00 -1250.00 159.00 -99.00 -260.61
PAT 5840.00 240.00 2333.33 5881.00 1053.00 458.50 1193.00 28484.00 -95.81
Equity 6003.00 6003.00 0.00 6003.00 6003.00 0.00 6003.00 6003.00 0.00
PBIDTM(%) 16.97 21.29 -20.28 18.35 22.86 -19.73 21.42 14.80 44.76

Biocon Share Price

380.55 -2.05 (-0.54%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×